Study to determine the presence of antipolymer antibodies in a group of Dutch women with a silicone breast implant

Clinical and Experimental Rheumatology

Volumn 20, Issue 2, 2002, Pages 151-160

  De Jong, W H ^a   Goldhoorn, C A ^a   Kallewaard, M ^a   Geertsma, R E ^a   Van Loveren, H ^a   Bijlsma, J W J ^a   Schouten, J S A G ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Antipolymer antibodies (APA); Polymer binding immunoglobulins; Silicone breast implant

Indexed keywords

IMMUNOGLOBULIN; POLYMER BINDING IMMUNOGLOBULIN; SILICONE; UNCLASSIFIED DRUG; ANTIBODY; POLYMER; SILICONE GEL;

ADULT; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; ASSAY; BLOOD SAMPLING; BREAST ENDOPROSTHESIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONSUMER; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; EXPOSURE; FEMALE; HUMAN; NETHERLANDS; PAIN ASSESSMENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECIPIENT; REGISTER; SELF REPORT; SILICONE PROSTHESIS; SYMPTOMATOLOGY; BLOOD; CROSS-SECTIONAL STUDY; FATIGUE; HOSPITALIZATION; MIDDLE AGED;

ADULT; ANTIBODIES; BREAST IMPLANTS; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; IMMUNOGLOBULINS; MIDDLE AGED; NETHERLANDS; POLYMERS; PREVALENCE; REGISTRIES; SEVERITY OF ILLNESS INDEX; SILICONE GELS;

EID: 0035990152     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. The basis of the FDA's decision on breast implants
2. Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies
3. Risk of connective-tissue diseases and other disorders after breast implantation
4. Silicone breast implants and the risk of connective-tissue diseases and symptoms
5. Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma)
6. Connective tissue disease and other rheumatic conditions following breast implants in Denmark
7. A clinical study of the relationship between silicone breast implants and connective tissue disease
8. Risk of connective tissue disease and related disorders among women with breast implants: A nation-wide retrospective cohort study in Sweden
9. A meta-analysis of breast implants and connective tissue disease
10. The association of augmentation mammoplasty with connective tissue disease, including systematic sclerosis (scleroderma): A meta-analysis
11. A review of the possible health implications of silicone breast implants
12. Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study
13. Reported complications of silicone gel breast implants: An epidemiologic review
14. Silicone breast implants in relation to connective tissue diseases and immunologic disfunction
15. Current scientific considerations in regard to a defining a "silicone syndrome"/disease and the formation of silica from silicone
16. Immunotoxicity of 180-day exposure to polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice
17. Silicone gels as adjuvants. Effects on humoral and cell-mediated immune responses
18. Subchronic 10 day immunotoxicity of polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice
19. Review of animal studies relevant to silicone toxicity
20. Immune functional impairment in patients with clinical abnormalities and silicone breast implants
21. The effect of silicone-gel on the immune response
22. The adjuvant effect of silicone gel and silicone elastomer particles in rats
23. The adjuvancy of silicones: Dependency on compartmentalization
24. Silicone gel and octamethylcyclotetrasiloxane potentiate antibody production to bovine serum albumin in mice
25. Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts
26. Human immune response to polydimethylsiloxane (silicone): Screening studies in a breast implant population
27. Antibody to silicone and native macromolecules in women with silicone breast implants
28. Immune reactions associated with sterile ventriculoperitoneal (VP) shunt malfunctions
29. The non-specific binding of immunoglobulins to silicone implant materials: The lack of a detectable silicone specific antibody
30. Modulation of IgG binding to silicone by human serum
31. Immunologic stimulation of T lymphocytes by silica after use of silicone mammary implants
32. T cell-mediated immune response to silica in silicone breast implant patients
33. Cellular immune reactivities in women with silicone breast implants: A preliminary investigation
34. Use of antipolymer antibody assay in recipients of silicone breast implants
35. Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity
36. Antipolymer antibodies, silicone breast implants, and fibromyalgia
37. Antipolymer antibodies, silicone breast implants, and fibromyalgia
38. Antipolymer antibodies, silicone breast implants; and fibromyalgia
39. Antipolymer antibodies, silicone breast implants, and fibromyalgia
40. Antipolymer antibodies, silicone breast implants, and fibromyalgia. Author's reply
41. Detection of antipolymer antibodies (APA) in serum of women with silicone breast implants. Introduction and performance of the assay in the RIVM
42. A connective tissue disease screening questionnaire for population studies
43. Verkorte vermoeidheidsvragenlijst: Een praktisch hulpmiddel bij het scoren van vermoeidheid
44. Study to the presence of antipolymer antibodies in a group of Dutch women with a silicone breast implant
45. Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis
46. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia
47. Diagnostic tests in the sicca syndrome
48. Therapeutic criteria in rheumatoid arthritis
49. The 1982 revised criteria for the classification of systemic lupus erythematosus
50. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
51. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
52. Sjogren's syndrome. Proposed criteria for classification